← Back to All Filings

CLOV Exec Sells $394K in Stock for Tax Withholding on RSUs

Low SignificanceNovember 4, 2025 at 6:31:43 PM EST

Subscribe to track CLOV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

CLOV Exec Sells $394K in Stock for Tax Withholding on RSUs

Company: CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Form: 4 | Filed: 2025-11-04 Significance: Low

Insider: Priest Brady Patrick Title: CEO of Home Care | Relationship: Officer

Transaction: • Type: Tax Withholding • Shares: 111,691 • Price: $3.53 • Value: $394,269 • Owned After: 2,228,583

Key Insight: This was an automatic sale to cover tax obligations from vesting RSUs, not a discretionary market sale. Such transactions are common and typically have low market significance.

Market Context: The transaction represents a negligible percentage of the company's market cap and outstanding shares.

Comprehensive Analysis

SEC Filing Analysis: CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer automatically sold shares to cover tax liabilities on vesting Restricted Stock Units (RSUs), a common and non-discretionary event.
  • Market Impact: The transaction is immaterial relative to the company's market capitalization and public float, suggesting a neutral market impact.

Company Information

FieldValue
CompanyCLOVER HEALTH INVESTMENTS, CORP. /DE
Ticker SymbolCLOV
CIK0001801170
IndustryHOSPITAL & MEDICAL SERVICE PLANS

Insider Information

FieldValue
NamePriest Brady Patrick
CIK0001938197
Title/PositionCEO of Home Care
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-31
Transaction CodeF (Withholding of securities to satisfy tax liabilities)
Security TypeClass A Common Stock
Shares Involved111,691
Price Per Share$3.53
Total Value$394,269.23
Shares Owned After2,228,583
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$394,269.23
% of Market Cap0.021%
Shares Transacted111,691
% of Shares Outstanding0.027%
Post-Transaction Ownership2,228,583 shares (0.53% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of ~$394k is negligible for a company with a $1.89 billion market capitalization.
  • Ownership Concentration: The insider's post-transaction ownership of 0.53% is a modest stake.
  • Transaction Significance: The sale represents less than 0.03% of shares outstanding and market cap, falling well below thresholds for significance. As a non-discretionary sale to cover taxes, it does not signal a change in the insider's sentiment towards the company.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is an automatic, tax-related disposition required upon the vesting of RSUs. It is not an open-market sale and therefore does not reflect the insider's investment decision or outlook.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The size of the transaction is too small relative to typical daily trading volume to have a noticeable effect.
  • Sentiment Indicator: Neutral. The market generally understands that 'sell-to-cover' transactions are procedural and not indicative of insider sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing footnotes explicitly state the shares were withheld to cover tax obligations related to the vesting of performance-based and time-based RSUs granted in October 2023. This is a routine corporate action.
Topics:#SECFiling#InsiderTrading#CLOV#CloverHealth#Form4#StockMarket#Investing#TaxWithholding

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.